Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 13, 2020
HTG Molecular Diagnostics announced the signing of a Commercialization and Distribution Agreement with QIAGEN Manchester Limited, a wholly owned subsidiary of QIAGEN.
read more
Thursday, August 13, 2020
Eyenovia has entered into a license agreement for Arctic Vision to develop and commercialize MicroPine in Greater China and South Korea.
read more
Thursday, August 13, 2020
Novel and generics pharma producer OncoGenerix and Alpha Capital have come to an agreement to build a new injectable pharmaceutical factory in the US.
read more
The Trendlines Group has expanded its activities to Shanghai with the establishment of Trendlines Medical Shanghai Innovation Center, which has recently started operations.
read more
Trxade announced that its Bonum Health subsidiary has launched a B2B platform which bundles telehealth, a COVID-19 risk assessment tool and a PPE purchasing tool, through a secure mobile dashboard for corporate clients.
read more
Bioanalytical Systems, doing business as Inotiv, announced I.M. Grossi, Ph.D., has joined the Company as Vice President, Toxicology.
read more
MyoKardia and LianBio have entered into a strategic collaboration to develop and commercialize mavacamten in China and other Asian territories.
read more
Blue Tech Industries has signed a Master Service Agreement with a new customer to manufacture the customer’s amniotic membrane platform for the next two years.
read more
Emmes announced that it provided the data and statistical analysis support for the Phase 1 clinical trial of the investigational COVID-19 vaccine mRNA-1273.
read more
Avacta Group announced the appointment of Neil Bell as Chief Development Officer of Avacta Life Sciences with immediate effect.
read more
JanOne has successfully completed the formulation of JAN101, its potential treatment for Peripheral Artery Disease expected to soon be in Phase 2b trials.
read more
Headlands Research announced its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine trial.
read more
ANA and Quotient Sciences announced a partnership to support the manufacturing of ANA001 as a potential treatment for COVID-19.
read more
Alimera Sciences Europe Limited has signed a distribution agreement with Nordic Prime ApS to serve as Alimera’s distribution partner in Denmark, Finland, Norway and Sweden for ILUVIEN® 190 micrograms intravitreal implant in applicator.
read more
RedHill Biopharma has entered into a binding term sheet with Cosmo Pharmaceuticals for an exclusive licensing and manufacturing agreement for multiple products.
read more